Viruzine Forte (500 mg/5 ml inosine pranobex)

CompositionThe active substance is inosine pranobex (complex containing inosine and 2- hydroxypropyl dimethyl ammonium 4-acetamidobenzoate in molar ratio 1:3). 1 ml of syrup contains 100 mg of inosine pranobex.5 ml of syrup contains 500 mg of inosine pranobex.

IndicationsViruzine Forte is an antiviral drug enhancing the body’s immunity (stimulates the immune system).Viruzine Forte contains the active substance – inosine pranobex inhibiting the in vitro replication of herpes viruses which are pathogenic to humans.Indications for use Viruzine Forte:– as supportive therapy in immunocompromised persons in case of recurrent upper respiratory tract infections,– in the treatment of lip and face herpes caused by the Herpes simplex virus. Viruzine Forte may be used only in patients with a history of diagnosed Herpes simplex virus infection.